# Ranolazine

NDC: 31722-669
Generic name: Ranolazine
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220505

FDA application: ANDA212788

## Active ingredients

- RANOLAZINE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-669"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-669
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82948cdb-73af-4f3f-bd03-628ed0fdbfba